THERAPEUTICSMD INC (TXMD)
US88338N2062 - Common Stock
ChartMill assigns a Buy % Consensus number of 43% to TXMD. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 5.1. This target is 351.33% above the current price.
TXMD was analyzed by 6 analysts. The buy percentage consensus is at 43. So analysts seem to be rather negative about TXMD.
In the previous month the buy percentage consensus was at a similar level.
TXMD was analyzed by 6 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2023-08-17 | Cantor Fitzgerald | Reiterate | Neutral -> Neutral |
| 2023-01-11 | Cantor Fitzgerald | Reiterate | Neutral |
| 2022-07-13 | Cantor Fitzgerald | Reiterate | Neutral |
| 2022-06-07 | HC Wainwright & Co. | Downgrade | Buy -> Neutral |
| 2022-05-06 | Cantor Fitzgerald | Downgrade | Overweight -> Neutral |
| 2022-03-11 | HC Wainwright & Co. | Maintains | Buy |
| 2021-11-12 | HC Wainwright & Co. | Maintains | Buy |